Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

The Bengaluru Score - a Prognostic Predictive Score for Clinical Efficacy Outcomes Based on Discovery Cohort of Patients Treated with Varnimcabtagene Autoleucel (IMN-003A) in the Phase-2 (IMAGINE) Study

Anil Kamat, Sharat Damodar, Sunil Bhat, Raja Thirumalairaj, Pankaj Malhotra, Pallavi Arasu, Mohammed Manzoor Akheel, Arun Anand

Blood (2023) 142 (Supplement 1): 6859.

https://doi.org/10.1182/blood-2023-181120

Published: 2023

Journal Articles

Varnimcabtagene Autoleucel (IMN-003A): Pharmacokinetic Profile with Predominant Naïve and Central Memory Phenotype Demonstrates Sustained In Vivo Persistence and Durable Responses in a First-in-India Industry Phase-2 Study (IMAGINE)

Blood (2023) 142 (Supplement 1): 6876.

https://doi.org/10.1182/blood-2023-179709

Published: 2023

Journal Articles

Modified Endothelial Activation and Stress Index (mEASIX) Score and Immune Effector Cell Associated Haematotoxicity (ICAHT) Following Varnimcabtagene Autoleucel (IMN-003A), a CD19-Directed Chimeric Antigen Receptor T (CAR-T) Cell Therapy, in the Phase-2 Study (IMAGINE)

Sunil Bhat, Sharat Damodar, Raja Thirumalairaj, Pankaj Malhotra, Pooja Mallya, Akshatha Nayak, Ravi Joshi, Revathy Raj, Charanpreet Singh, Rameez Ahamed, Manjunatha BR, Pallavi Arasu, Sri Ramulu Elluru, Mohammed Manzoor Akheel, Anil Kamat

Blood (2023) 142 (Supplement 1): 6856.

https://doi.org/10.1182/blood-2023-180478

Published: 2023

Journal Articles

Cytokine Profile Following Varnimcabtagene Autoleucel (IMN-003A) in Patients with Relapsed Refractory B Cell Malignancies in the First-in-India Industry Phase-2 Study (IMAGINE)

Sharat Damodar, Sunil Bhat, Raja Thirumalairaj, Pankaj Malhotra, Sudeshna Dhar, Sandeepa Shetty, Mani Bharathi T.I., Anne Roshan Joseph, Gowri Shankar Krishnan, Pallavi Arasu, Sri Ramulu Elluru, Mohammed Manzoor Akheel, Rahul Nahar, Lakshmikanth Gandikota, Anil Kamat

Blood (2023) 142 (Supplement 1): 6862.

https://doi.org/10.1182/blood-2023-181585

Published: 2023

Journal Articles

Factors Associated with Refractoriness or Relapse after Varnimcabtagene Autoleucel (IMN-003A) in Patients with Relapsed Refractory B Cell Malignancies: Phase 2 First-in-India Industry (IMAGINE) Study

Blood (2023) 142 (Supplement 1): 6879.

https://doi.org/10.1182/blood-2023-181112

Published: 2023

Journal Articles

Hypogammaglobulinemia and Infection Risk in Relapsed Refractory B Cell Malignancy Patients Treated with Varnimcabtagene Autoleucel (IMN-003A), a CD19-Directed Chimeric Antigen Receptor T (CAR-T) Cell Therapy, in the Phase-2 Study (IMAGINE)

Sharat Damodar, Sunil Bhat, Raja Thirumalairaj, Pankaj Malhotra, Akshatha Nayak, Pooja Mallya, Ravi Joshi, Revathy Raj, Rameez Ahamed, Charanpreet Singh, Raja B, Pallavi Arasu, Sri Ramulu Elluru, Mohammed Manzoor Akheel, Anil Kamat

Blood (2023) 142 (Supplement 1): 6853.

https://doi.org/10.1182/blood-2023-179833

Published: 2023

Journal Articles

Varnimcabtagene Autoleucel (IMN-003A): Differences in T Cell Subset Phenotype in B-ALL and B-NHL Cohorts Did Not Influence Efficacy Outcomes in the Phase-2 Study (IMAGINE)

Blood (2023) 142 (Supplement 1): 6881.

https://doi.org/10.1182/blood-2023-184521

Published: 2023

Journal Articles

Primary Analysis of Varnimcabtagene Autoleucel (IMN-003A) in Phase 2 Study (IMAGINE), a First-in-India Industry CD19-Directed CAR-T Cell Therapy for Patients with Relapsed Refractory B Cell Malignancies

Blood (2023) 142 (Supplement 1): 2104.

https://doi.org/10.1182/blood-2023-179424

Published: 2023

Journal Articles

Early Results from a Phase-2 Study of Varnimcabtagene Autoleucel (IMN-003A), a First-in-India Industry CD19-Directed CAR-T Cell Therapy with Fractionated Infusions for Patients with Relapsed and/or Refractory B Cell Malignancies (IMAGINE Study)

Sharat Damodar, Sunil Bhat, Akshatha Nayak, Pooja Mallya, Bharath Ram S, Ravi Joshi, Deepak MB, Sudarshan Chougule, Anne Roshan Joseph, Gopinadh Jakka, Sudeshna Dhar, Arun Kumar MG, Murugan Palanisamy, Sri Ramulu Elluru, Mohammed Manzoor Akheel, Arun Anand, Anil Kamat

Blood (2022) 140 (Supplement 1): 10343–10344.

https://doi.org/10.1182/blood-2022-166297

Published: 2022

Journal Articles

Response, Peak and Persistence of Varnimcabtagene Autoleucel (IMN-003A), First-in-India Industry CD19-Directed CAR-T Cell Therapy, with Fractionated Infusions for Patients with Relapsed and/or Refractory B Cell Malignancies: Early Results (IMAGINE Study)

Sunil Bhat, Sharat Damodar, Pooja Mallya, Akshatha Nayak, Ravi Joshi, Bharath Ram S, Sudarshan Chougule, Deepak MB, Gopinadh Jakka, Sudeshna Dhar, Anne Roshan Joseph, Arun Kumar MG, Murugan Palanisamy, Jeetendra Kumar, Melina Soares, Pallavi Arasu, Sri Ramulu Elluru, Mohammed Manzoor Akheel, Anil Kamat

Blood (2022) 140 (Supplement 1): 7478–7479.

https://doi.org/10.1182/blood-2022-166650

Published: 2022

Journal Articles

A Prospective Analysis of the Genomic Landscape of Patients with Acute Myeloid Leukemia and Its Impact on Clinical Outcomes - Data from a Tertiary Care Center in India

Hamza Yusuf Dalal, MD DNB, Sharat Damodar, MBBS, MD DM, Vidya Harini Veldore, PhD, Coral Miriam K, PhD, Shilpa Prabhu, MBBS, MD, Mukesh Chawla, MBBS, MD DNB, Bharathram S, MBBS, MD DNB, Amarnadh Polisetty, DNB, Aditi Shah, MBBS, MD DNB, Shivakumar Komaravelli, MBBS, MD DNB, Vedam L Ramprasad, PhD, Sunil Bhat, MBBS, MD, Shoba Badiger, MD, Nataraj KS, MD DM

Blood (2019) 134 (Supplement_1): 5163.

https://doi.org/10.1182/blood-2019-130000

Published: 2019

Journal Articles

Retrospective Next Generation DNA Sequencing Analysis in Patients with Hemophagocytic Lymphohistiocytosis (HLH) Highlights Genetic Variants Associated with Secondary/Late-Onset Disease

Meeta Sunil, Chirantan Bose, Coral Karunakaran, Sunil Bhat, MBBS, MD, Nita Radhakrishnan, Srisha Rani, Sakthivel Murugan SM, Sharat Damodar, MBBS, MD DM, Ravi Gupta, Rohit Gupta, Mukesh Manharlal Desai, MBBS,MD, Arati Khanna-Gupta, PhD

Blood (2017) 130 (Supplement 1): 2286.

https://doi.org/10.1182/blood.V130.Suppl_1.2286.2286

Published: 2017

Journal Articles

Minimal Residual Disease (MRD) Assessment after Induction Chemotherapy in Children and Adults with Acute Lymphoblastic Leukemia (ALL): A Valuable Strategy in Resource Constraint Settings in the Indian Subcontinent

Karuna kUMAR, MD, Swasti Sinha, Vellaichamy Annapandian, Nataraj KS, MD DM, Shoba Badiger, MD, Sunil Bhat, MBBS, MD, Sharat Damodar, MBBS, MD DM

Blood (2017) 130 (Supplement 1): 5126.

https://doi.org/10.1182/blood.V130.Suppl_1.5126.5126

Published: 2017

Journal Articles

Day 5 Peripheral Blood Blasts and Day 14 Bone Marrow Studies As Predictors for Response to Therapy in Acute Myeloid Leukemia (AML): An Experience from Indian Subcontinent

Shilpa Prabhu, MBBS, MD, Nataraj KS, MD DM, Sharat Damodar, MBBS, MD DM, Swasti Sinha, Sunil Bhat, MBBS, MD, Shoba Badiger, MD, Vellaichamy Annapandian

Blood (2017) 130 (Supplement 1): 5019.

https://doi.org/10.1182/blood.V130.Suppl_1.5019.5019

Published: 2017

Journal Articles

Outcome of Allogeneic Stem Cell Transplantation for Thalassemia Major in India

Fouzia NA, Dip NB, DM,, Revathi Raj, MD, Dharma Choudhary, MD DM, Sharat Damodar, MD DM, Shashikant Apte, MD FRCPA, M Joseph John, MD DM, Ashish Dixit, MD DM, Kannan Subramanyan, DipNB, DM, Jose Easow, MD, Sunil Bhat, MBBS, MD FPHO, Chepsy C Philip, MD DM, Amrith Mathew, MD, Kavitha M Lakshmi, MSc, Anu Korula, MD DM, Aby Abraham, MD DM, Auro Viswabandya, MD DM, Alok Srivastava, MD FRACP

Blood (2015) 126 (23): 3219.

https://doi.org/10.1182/blood.V126.23.3219.3219

Published: 2015

Journal Articles

Improved Outcomes with Allogeneic Stem Cell Transplantation for Aplastic Anaemia Using HLA Identical Sibling Donors: The Indian Stem Cell Transplant Registry (ISCTR) Experience

Biju George, DM, Manoranjan Mahapatra, Pravas Mishra, DM, Shashikant Apte, MD FRCPA, Sharat Damodar, MD DM, Navin Khattry, MDDM, Dharma Choudhary, MD DM, Jose Easow, MD, Revathi Raj, Tulika Seth, MD, Soniya Nityanand, MDPhD, Pankaj Malhotra, MD Additional Professor, Dinesh Bhurani, MD, Ashish Dixit, MD DM, Ajay Sharma, MD, Anupam Chakrapani, MBBS, MD DM, Sameer Ramesh Melinkeri, MD, Joseph M John, DM, Sunil Bhat, MBBS, MD FPHO, Neeraj Sidharthan, Bhausaheb Bagal, MD DM, Aby Abraham, MD DM, Ramesh Nimmagadda, T Raja, Abhijeet Ganapule, DM, V Lakshmanan, Fouzia Nambiathayil Abubacker, DM, Anu Korula, MD DM, Satyaranjan Das, Sanjeevan Sharma, Kannan Subramaniam, Rayaz Ahmed, MDDM, Narendra Agarwal, Alka Khadwal, MD, Gaurav Prakash, MBBS, MD DM, Amit Rauthan, DM, Chirag Shah, Uday Deotare, MD DM, MBBS, MNAMS, Sanjeev Kumar Sharma, MD DM, Seema S. Bhatwadekar, MD, Chandran K Nair, MD, Kavitha Lakshmi, MSc, Velu Nair, Mammen Chandy, MD, Alok Srivastava, MD FRACP, Vikram Mathews, DM

Blood (2015) 126 (23): 4386.

https://doi.org/10.1182/blood.V126.23.4386.4386

Published: 2015

Journal Articles

Allogeneic Hematopoietic Stem Transplantation in Patients with Transfusion Dependent Beta Thalassemia: A Single-Center Experience from India

Sunil Bhat, MBBS, MD FPHO, Akshatha Nayak, Shobha Badiger, Nataraj K. S, Sharat Damodar, MD

Blood (2014) 124 (21): 5937.

https://doi.org/10.1182/blood.V124.21.5937.5937

Published: 2014

Journal Articles

Successful Control of Massive Gastrointestinal Bleeding Following Umbilical Cord Blood Transplantation (UCBT) by Use of Recombinant Activated Factor VII (rFVIIa) and Octreotide Infusion

Satya Prakash Yadav, MBBS, DCH, DNB, Anupam Sachdeva, Madasu Anjan, Nita Radhakrishnan, Sunil Bhat, Manas Kalra, Satyendra Katewa

Blood (2008) 112 (11): 4336.

https://doi.org/10.1182/blood.V112.11.4336.4336

Published: 2008

NARROW

The Bengaluru Score - a Prognostic Predictive Score for Clinical Efficacy Outcomes Based on Discovery Cohort of Patients Treated with Varnimcabtagene Autoleucel (IMN-003A) in the Phase-2 (IMAGINE) Study

Varnimcabtagene Autoleucel (IMN-003A): Pharmacokinetic Profile with Predominant Naïve and Central Memory Phenotype Demonstrates Sustained In Vivo Persistence and Durable Responses in a First-in-India Industry Phase-2 Study (IMAGINE)

Modified Endothelial Activation and Stress Index (mEASIX) Score and Immune Effector Cell Associated Haematotoxicity (ICAHT) Following Varnimcabtagene Autoleucel (IMN-003A), a CD19-Directed Chimeric Antigen Receptor T (CAR-T) Cell Therapy, in the Phase-2 Study (IMAGINE)

Cytokine Profile Following Varnimcabtagene Autoleucel (IMN-003A) in Patients with Relapsed Refractory B Cell Malignancies in the First-in-India Industry Phase-2 Study (IMAGINE)

Factors Associated with Refractoriness or Relapse after Varnimcabtagene Autoleucel (IMN-003A) in Patients with Relapsed Refractory B Cell Malignancies: Phase 2 First-in-India Industry (IMAGINE) Study

Hypogammaglobulinemia and Infection Risk in Relapsed Refractory B Cell Malignancy Patients Treated with Varnimcabtagene Autoleucel (IMN-003A), a CD19-Directed Chimeric Antigen Receptor T (CAR-T) Cell Therapy, in the Phase-2 Study (IMAGINE)

Varnimcabtagene Autoleucel (IMN-003A): Differences in T Cell Subset Phenotype in B-ALL and B-NHL Cohorts Did Not Influence Efficacy Outcomes in the Phase-2 Study (IMAGINE)

Primary Analysis of Varnimcabtagene Autoleucel (IMN-003A) in Phase 2 Study (IMAGINE), a First-in-India Industry CD19-Directed CAR-T Cell Therapy for Patients with Relapsed Refractory B Cell Malignancies

Early Results from a Phase-2 Study of Varnimcabtagene Autoleucel (IMN-003A), a First-in-India Industry CD19-Directed CAR-T Cell Therapy with Fractionated Infusions for Patients with Relapsed and/or Refractory B Cell Malignancies (IMAGINE Study)

Response, Peak and Persistence of Varnimcabtagene Autoleucel (IMN-003A), First-in-India Industry CD19-Directed CAR-T Cell Therapy, with Fractionated Infusions for Patients with Relapsed and/or Refractory B Cell Malignancies: Early Results (IMAGINE Study)

A Prospective Analysis of the Genomic Landscape of Patients with Acute Myeloid Leukemia and Its Impact on Clinical Outcomes - Data from a Tertiary Care Center in India

Retrospective Next Generation DNA Sequencing Analysis in Patients with Hemophagocytic Lymphohistiocytosis (HLH) Highlights Genetic Variants Associated with Secondary/Late-Onset Disease

Minimal Residual Disease (MRD) Assessment after Induction Chemotherapy in Children and Adults with Acute Lymphoblastic Leukemia (ALL): A Valuable Strategy in Resource Constraint Settings in the Indian Subcontinent

Day 5 Peripheral Blood Blasts and Day 14 Bone Marrow Studies As Predictors for Response to Therapy in Acute Myeloid Leukemia (AML): An Experience from Indian Subcontinent

Outcome of Allogeneic Stem Cell Transplantation for Thalassemia Major in India

Improved Outcomes with Allogeneic Stem Cell Transplantation for Aplastic Anaemia Using HLA Identical Sibling Donors: The Indian Stem Cell Transplant Registry (ISCTR) Experience

Allogeneic Hematopoietic Stem Transplantation in Patients with Transfusion Dependent Beta Thalassemia: A Single-Center Experience from India

Successful Control of Massive Gastrointestinal Bleeding Following Umbilical Cord Blood Transplantation (UCBT) by Use of Recombinant Activated Factor VII (rFVIIa) and Octreotide Infusion

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only